Ayalon Insurance Company’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,711
Closed -$17K 87
2023
Q3
$17K Hold
1,711
0.01% 82
2023
Q2
$17K Hold
1,711
0.01% 84
2023
Q1
$16K Hold
1,711
0.01% 96
2022
Q4
$19K Hold
1,711
0.01% 99
2022
Q3
$15K Hold
1,711
0.01% 103
2022
Q2
$18K Sell
1,711
-744
-30% -$8.16K 0.01% 97
2022
Q1
$27K Hold
2,455
0.01% 126
2021
Q4
$33K Hold
2,455
0.01% 122
2021
Q3
$33K Sell
2,455
-843
-26% -$12K 0.01% 122
2021
Q2
$49K Buy
3,298
+148
+5% +$2.14K 0.02% 151
2021
Q1
$44K Hold
3,150
0.02% 142
2020
Q4
$59K Buy
+3,150
New +$51.4K 0.03% 126

Other funds holding VTRS

Ayalon Insurance Company's VTRS Position: Q4 2023 in Review

Ayalon Insurance Company sold out of Viatris (VTRS) in Q4 2023, closing a stake of 1,711 shares — an estimated $17K sold.

Ayalon Insurance Company first reported a position in VTRS in Q4 2020 and held it in 12 quarters. The position peaked at $59K in Q4 2020. 1,014 funds tracked by Wall St. Rank hold VTRS as of Q4 2023.

  • Ayalon Insurance Company reported no remaining Viatris position as of Q4 2023 after selling out during the quarter.
  • Ayalon Insurance Company sold 1,711 Viatris shares in Q4 2023, an estimated $17K.
  • Ayalon Insurance Company first reported a position in Viatris in Q4 2020 and held it in 12 quarters.
  • Ayalon Insurance Company's Viatris position peaked at $59K in Q4 2020.
  • 1,014 funds tracked by Wall St. Rank held Viatris as of Q4 2023.

Based on Ayalon Insurance Company's 13F filing for Q4 2023, filed 16 Jan 2024.